Efficacy of Electroacupuncture with different frequencies in the treatment of chemotherapy-induced peripheral neuropathy: a randomized controlled study

Phase 1

Not yet recruiting

• Conditions: Cancer; Peripheral nerve diseases

• Registration Number: ITMCTR2100005420
• Lead Sponsor: Zhejiang Cancer Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Over 18 and under 70 years old, and the expected survival time was = 1 year; (2) Pathological diagnosis was malignant tumor, and peripheral neurotoxicity above grade 1 occurred after chemotherapy with platinum, paclitaxel and vinblastine; (3) Have daily living ability, no hearing loss, and can cooperate independently to complete all examinations; (4) No serious heart, liver, brain, kidney and other diseases, Karnofsky functional status score (KPS)>60; (5) Clear consciousness without mental illness or cognitive impairmen; (6) Signed the written informed consent form for the clinical trial.

Exclusion Criteria

(1) Diagnoses of relatively severe systemic diseases (cardiovascular disease, acute infectious disease, haematopathy, endocrinopathy, allergy or methysis); (2) Diagnoses of depression, anxiety, schizophrenia orother severe mental disorders; (3) Diagnosed as peripheral neuropathy caused by other causes, such as peripheral nerve injury or diabetic peripheral neuropathy; (4) Pregnant and lactating women; (5) Alcohol and/or other drug abuse or dependen; (6) Participating in other clinical trials of acupuncture or drugs.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified